Your browser doesn't support javascript.
loading
Fetal PR Interval in Pregnancies with Intrahepatic Cholestasis of Pregnancy: A Case-Control Study.
Guerra, Manuel; Montaño, Ignacio; Haye, María T; Toro, Victoria; Maiz, Nerea.
Afiliação
  • Guerra M; Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Clínico San José, Santiago, Chile.
  • Montaño I; Department of Perinatology, Clínica Redsalud Vitacura, Santiago, Chile.
  • Haye MT; Universitat Autònoma de Barcelona, Bellaterra, Spain.
  • Toro V; Maternal-Fetal Medicine Unit, Department of Obstetrics and Gynecology, Hospital Clínico San José, Santiago, Chile.
  • Maiz N; Department of Ultrasonography, Clínica Indisa, Santiago, Chile.
Am J Perinatol ; 2023 Nov 21.
Article em En | MEDLINE | ID: mdl-37774745
OBJECTIVE: This study had three purposes: first, to explore differences in fetal cardiac function in patients with and without intrahepatic cholestasis of pregnancy (ICP) based on PR interval (the interval between the beginning of the atrial contraction and the beginning of the ventricular contraction). Second, to explore a potential correlation between PR interval and bile acid levels in pregnant women with ICP. Third, to study changes in PR interval of fetuses from pregnant women with ICP after administration of ursodeoxycholic acid (UDCA). STUDY DESIGN: This was a prospective observational case-control study. ICP was defined as palmar plantar pruritus of nocturnal predominance for more than 1 week associated with a total bile acid level >10 µmol/L. Control cases were women with pregnancies scheduled for induction or elective cesarean section at term. RESULTS: One hundred and ten women with ICP and 72 controls were included in the study. Median gestational age at inclusion was 35.9 weeks. Median PR interval was significantly longer in fetuses of women with ICP (122 vs. 102 ms, p < 0.001). There was a significant correlation between bile acid levels and PR interval (rho = 0.723, p < 0.001). In 22 fetuses, the median PR interval decreased significantly following UDCA administration (134 vs. 118 ms, p = 0.004). CONCLUSION: PR interval is longer in fetuses of women with ICP. PR interval was significantly correlated with bile acid levels, and administration of UDCA significantly reduced PR interval. KEY POINTS: · Differences in fetal cardiac function in patients with and without intrahepatic cholestasis.. · PR interval and bile acid levels in pregnant women with intrahepatic cholestasis.. · Changes in PR interval of fetuses from pregnant women with ICP after use of UDCA..

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article